136 related articles for article (PubMed ID: 34402262)
1. Development of a nomogram for predicting survival of patients with ovarian serous cystadenocarcinoma after based on SEER database.
Chen X; Guo T
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 50(3):369-374. PubMed ID: 34402262
[TBL] [Abstract][Full Text] [Related]
2. A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.
Yang L; Yu J; Zhang S; Shan Y; Li Y; Xu L; Zhang J; Zhang J
J Ovarian Res; 2022 Feb; 15(1):26. PubMed ID: 35168642
[TBL] [Abstract][Full Text] [Related]
3. Bladder cancer survival nomogram: Development and validation of a prediction tool, using the SEER and TCGA databases.
Zhang Y; Hong YK; Zhuang DW; He XJ; Lin ME
Medicine (Baltimore); 2019 Nov; 98(44):e17725. PubMed ID: 31689813
[TBL] [Abstract][Full Text] [Related]
4. Nomogram for predicting cancer-specific survival in undifferentiated pleomorphic sarcoma: A Surveillance, Epidemiology, and End Results -based study.
Xu F; Zhao F; Feng X; Li C; Han D; Zheng S; Liu Y; Lyu J
Cancer Control; 2021; 28():10732748211036775. PubMed ID: 34405711
[TBL] [Abstract][Full Text] [Related]
5. Development and identification of a prognostic nomogram model for patients with mixed cell adenocarcinoma of the ovary.
Wu H; Jiang S; Zhong P; Li W; Zhang S
J Ovarian Res; 2021 Oct; 14(1):137. PubMed ID: 34674727
[TBL] [Abstract][Full Text] [Related]
6. Predictive Nomogram for Midterm to Long-Term Prognosis in Patients with Papillary Renal Cell Carcinoma Based on Data from the Surveillance, Epidemiology, and End Results (SEER) Program.
Wang H; Chen X; Zhao J; Kang M; Dong R; Wang K; Qu Y
Med Sci Monit; 2020 Jun; 26():e921859. PubMed ID: 32570266
[TBL] [Abstract][Full Text] [Related]
7. Calculating the overall survival probability in patients with cervical cancer: a nomogram and decision curve analysis-based study.
Xie G; Wang R; Shang L; Qi C; Yang L; Huang L; Yang W; Chung MC
BMC Cancer; 2020 Sep; 20(1):833. PubMed ID: 32873257
[TBL] [Abstract][Full Text] [Related]
8. A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.
Shan Q; Shi J; Wang X; Guo J; Han X; Wang Z; Wang H
BMC Cancer; 2021 May; 21(1):640. PubMed ID: 34051733
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of nomograms for predicting survival of elderly patients with stage I small-cell lung cancer.
Yang Y; Sun S; Wang Y; Xiong F; Xiao Y; Huang J
Bosn J Basic Med Sci; 2021 Oct; 21(5):632-641. PubMed ID: 33577444
[TBL] [Abstract][Full Text] [Related]
10. Score for the Risk and Overall Survival of Lung Metastasis in Patients First Diagnosed With Soft Tissue Sarcoma: A Novel Nomogram-Based Risk Assessment System.
Fan Z; Chi C; Tong Y; Huang Z; Song Y; You S
Technol Cancer Res Treat; 2022; 21():15330338211066240. PubMed ID: 35006028
[No Abstract] [Full Text] [Related]
11. Development and validation of a SEER-based prognostic nomogram for cervical cancer patients below the age of 45 years.
Liu Q; Li W; Xie M; Yang M; Xu M; Yang L; Sheng B; Peng Y; Gao L
Bosn J Basic Med Sci; 2021 Oct; 21(5):620-631. PubMed ID: 33485294
[TBL] [Abstract][Full Text] [Related]
12. A nomogram to predict the cancer-specific survival of stage II-IV Epithelial ovarian cancer after bulking surgery and chemotherapy.
Zhao L; Yu P; Zhang L
Cancer Med; 2021 Jul; 10(13):4344-4355. PubMed ID: 34057318
[TBL] [Abstract][Full Text] [Related]
13. A convenient clinical nomogram for predicting the cancer-specific survival of individual patients with small-intestine adenocarcinoma.
Wang N; Yang J; Lyu J; Liu Q; He H; Liu J; Li L; Ren X; Li Z
BMC Cancer; 2020 Jun; 20(1):505. PubMed ID: 32487033
[TBL] [Abstract][Full Text] [Related]
14. Prognostic nomograms and Aggtrmmns scoring system for predicting overall survival and cancer-specific survival of patients with kidney cancer.
Zhou Y; Zhang R; Ding Y; Wang Z; Yang C; Tao S; Liang C
Cancer Med; 2020 Apr; 9(8):2710-2722. PubMed ID: 32087609
[TBL] [Abstract][Full Text] [Related]
15. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
Wang B; Wang S; Ren W
BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
[TBL] [Abstract][Full Text] [Related]
16. Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3.
Wang J; Chen L; Nie Y; Wu W; Yao Y
Clin Breast Cancer; 2020 Dec; 20(6):e778-e785. PubMed ID: 32636150
[TBL] [Abstract][Full Text] [Related]
17. Exploration and prognostic analysis of two types of high-risk ovarian cancers: clear cell vs. serous carcinoma: a population-based study.
Liu T; Gao Y; Li S; Xu S
J Ovarian Res; 2024 Jun; 17(1):119. PubMed ID: 38824600
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a nomogram to predict the prognosis of patients with gastric cardia cancer.
Shi X; Xu L; Ma B; Wang S
Sci Rep; 2020 Aug; 10(1):14143. PubMed ID: 32839498
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study.
Yang Z; Bai Y; Liu M; Hu X; Han P
Cancer Med; 2020 Dec; 9(24):9303-9314. PubMed ID: 33063464
[TBL] [Abstract][Full Text] [Related]
20. A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC).
Chen L; Liu X; Li M; Wang S; Zhou H; Liu L; Cheng X
Cancer Med; 2020 Feb; 9(3):988-998. PubMed ID: 31846222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]